Although p16INK4A is used as a surrogate marker for HPV-associated cervical cancer and head and neck cancer, the prevalence of HPV infection in p16INK4A-positive and p16INK4A-negative specimens demonstrated no statistically significant difference (correlation coefficient = -0.062, p = 0.499). This evidence concerns the gene CDKN2A and cervical cancer.